March 12, 2025 - 18:55

US stock futures experienced an uptick as investors reacted positively to recent inflation data, which appeared to alleviate some concerns surrounding the economy. The latest reports indicated a slowdown in inflation, providing a glimmer of hope for market stability. This optimism comes in the wake of a tumultuous trading day on Wall Street, where fluctuations were driven by the rapid developments in President Donald Trump's trade policy.
Market analysts noted that the calming inflation figures could encourage investors to re-enter the market, potentially leading to a more sustained recovery. The positive sentiment was reflected across various sectors, with futures indicating a broad-based rally. As traders assessed the implications of the new economic data, many expressed cautious optimism about the future trajectory of the market.
The interplay between trade policies and economic indicators continues to be a focal point for investors, as they navigate the complexities of the current financial landscape. With inflation concerns easing, market participants are hopeful for a more stable environment moving forward.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...